Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
QLT Add to My Watchlist (NSDQ: QLTI) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     QLT 4.48 -0.03 (-0.67%) 67,253
101-887 Great Northern Way
Vancouver, B.C., V5T 4T5 CN
(604) 707-7000
(604) 707-7001 fax
www.qltinc.com
CEO Robert L. Butchofsky
Auditor Deloitte & Touche L.L.P.
Exchange Traded NQ
ISIN Number CA7469271026
CIK Number 827809
NAICS Code 325412
Business Summary
A global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.
Number of Employees 254
Share Fundamentals
Market Cap 240.98M
Shares Outstanding 53.79M
Float 54.24M
Short Interest 993.15K
Financial Strength
Revenue (TTM) $118,782,000
Earnings (TTM) $24,725,000
Quick Ratio 10.4:1
Current Ratio 13.9:1
Total Debt/Equity 0:1
Profitability
Gross Margin 37.5%
EBITDA Margin -3.0%
Profit Margin 43.5%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs